Search details
1.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Article
in English
| MEDLINE | ID: mdl-32929488
2.
Patient-derived xenografts, the cancer stem cell paradigm, and cancer pathobiology in the 21st century.
Lab Invest
; 93(9): 970-82, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23917877
3.
Tretinoin Enhances the Effects of Chemotherapy in Juvenile Myelomonocytic Leukemia Using an Ex Vivo Drug Sensitivity Assay.
JCO Precis Oncol
; 7: e2300302, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37944074
4.
Oncogenic Kras initiates leukemia in hematopoietic stem cells.
PLoS Biol
; 7(3): e59, 2009 Mar 17.
Article
in English
| MEDLINE | ID: mdl-19296721
5.
Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia.
Front Oncol
; 12: 832816, 2022.
Article
in English
| MEDLINE | ID: mdl-35223511
6.
Ex Vivo Drug Sensitivity Correlates with Clinical Response and Supports Personalized Therapy in Pediatric AML.
Cancers (Basel)
; 14(24)2022 Dec 18.
Article
in English
| MEDLINE | ID: mdl-36551725
7.
Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.
J Biol Chem
; 285(43): 32834-32843, 2010 Oct 22.
Article
in English
| MEDLINE | ID: mdl-20729212
8.
Ex vivo drug screening defines novel drug sensitivity patterns for informing personalized therapy in myeloid neoplasms.
Blood Adv
; 4(12): 2768-2778, 2020 06 23.
Article
in English
| MEDLINE | ID: mdl-32569379
9.
Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study.
Clin Cancer Res
; 26(3): 726-737, 2020 02 01.
Article
in English
| MEDLINE | ID: mdl-31719049
10.
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions.
Clin Cancer Res
; 21(18): 4165-73, 2015 Sep 15.
Article
in English
| MEDLINE | ID: mdl-26015513
11.
JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal.
Cancer Cell
; 15(4): 341-52, 2009 Apr 07.
Article
in English
| MEDLINE | ID: mdl-19345332
12.
Differential regulation of CDP/Cux p110 by cyclin A/Cdk2 and cyclin A/Cdk1.
J Biol Chem
; 280(38): 32712-21, 2005 Sep 23.
Article
in English
| MEDLINE | ID: mdl-16081423
13.
Expression of N-terminally truncated isoforms of CDP/CUX is increased in human uterine leiomyomas.
Int J Cancer
; 100(4): 429-32, 2002 Aug 01.
Article
in English
| MEDLINE | ID: mdl-12115525
Results
1 -
13
de 13
1
Next >
>>